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Abstract Diabetes mellitus is associated with increased risk
for atherosclerotic cardiovascular disease (CVD). Recent
prospective studies in healthy individuals suggest that the
postprandial triglyceride (TG) level is a better independent
predictor for assessing future CVD events than fasting TG
levels. In contrast, results have been more controversial among
diabetic patients, as some studies report a positive association
between postprandial TG and CVD. This raises the issue of to
what extent postprandial TG levels may be of predictive value
in the diabetic population. One possibility impacting on the
predictive power of postprandial TG in identifying CVD risk
may be the presence of other risk factors, including alterations
in lipid and lipoprotein metabolism, which could make it more
difficult to identify the impact of postprandial lipemia on
cardiovascular risk. The findings provide a challenge to
develop a better approach to assess the impact of postprandial
lipemia on CVD risk under diabetic conditions.
Keywords Diabeticdyslipidemia.Postprandial
triglyceride.Cardiovascularrisk.Diabeticandnondiabetic
population
Introduction
The prevalence of type 2 diabetes mellitus (DM) has grown
rapidly in Westernized and developing countries, making it
oneofthe mostcommondiseasesinthe world.Thenumberof
adults with DM worldwide is estimated to increase from 135
million in 1995 to 300 million in 2025 [1]. This has a
significant negative health care potential, as DM is associ-
ated with a twofold to fourfold increased risk for develop-
ment of atherosclerotic cardiovascular disease (CVD) [1],
particularly coronary artery disease (CAD), and a threefold
to eightfold greater risk for mortality from CVD. The high
risk for CVD is underscored by the similar risks for a future
CVD event in individuals with DM without a history of a
prior myocardial infarction (MI), and in individuals without
DM with a previous MI [2]. Moreover, more than 50% of all
deaths among men or women with DM are attributable to
CVD complications. These facts generally have been
attributed to a high burden of risk factors such as
hypertension, obesity, smoking, hyperglycemia, and dyslipi-
demia, many of which are associated with insulin resistance,
resulting in a high cardiovascular risk phenotype among
individuals with DM [3]. Among these risk factors, diabetic
dyslipidemia is characterized by elevated levels of fasting
triglyceride (TG); decreased levels ofhigh-density lipoprotein
(HDL) cholesterol; and presence of small, dense, low-density
lipoprotein (LDL) cholesterol particles. It is noteworthy that
TG and HDL cholesterol are powerful predictors of the
postprandial response. In keeping with this, previous studies
haveshownanincreasedpostprandialdyslipidemiainpatients
with DM regardless of elevated fasting TG concentrations [4,
5]. However, the potential role of postprandial conditions in
the development of atherosclerosis is not well established in
the diabetic population. Particularly, whereas recent studies
have provided evidence for an association of elevated
postprandial TG with an increased CVD risk in the general
population, this issue has not been investigated to the same
extent in the diabetic population.
Postprandial Assessment: Methodological Aspects
Accumulating evidence suggests that elevated levels of
fasting and postprandial TG predict higher CVD risk [6, 7,
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DOI 10.1007/s11892-009-0088-48•, 9•]. The postprandial state is characterized by a rapid
rise in triglyceride-rich lipoproteins (TRLs) derived from
the intestine as chylomicrons, containing apolipoprotein
(apo) B-48, and from the liver as very low density
lipoprotein (VLDL), containing apo B-100. Although a
close relationship exists between fasting and postprandial
TG levels, intraindividual differences in TG levels between
fasting and postprandial conditions vary substantially,
partly due to differences in insulin sensitivity [10].
Although most studies of cardiovascular risk to date have
focused on fasting conditions, recent studies have demon-
strated that the postprandial TG level was a better
independent predictor than the fasting TG level for
assessing present and future CVD events in the nondiabetic
population [11••]. Furthermore, increasing postprandial TG
levels are more strongly and directly related to remnant
lipoprotein concentrations than fasting TG levels [12••, 13].
This raises the possibility that risk for cardiovascular events
may also be due to an increase in remnant lipoproteins in
the postprandial state. The importance of postprandial TG
in the prediction of CVD derives from the fact that in
humans, most of the day is spent in this state. Studies that
have monitored TG responses overnight following a fat-
containing evening meal have shown values to be elevated
for 7–8 h after the meal, only falling toward fasting values
between 4 AM and 6 AM [14].
Determination of the postprandial response itself is
complex and goes beyond TG levels. Therefore, it has
been challenging to assess the CVD risks associated with
the postprandial state. Researchers have used several tools
to investigate the postprandial lipemic responses, including
responses to a metabolic challenge (fat tolerance or oral fat-
loading test) or a normal food intake, as well as use of self-
determined diurnal capillary TG measurement [9•, 12••, 15,
16]. Typically, the oral fat load includes the administration
of a test meal or drink with a high fat content (eg, 1 g/fat
per kilogram of body weight) after an overnight fast. The
increase in postprandial TG levels depends on the amount
of dietary fat in the test meal; a very low (5 g) or low
(<15 g) dose of dietary fat generally does not increase
postprandial TG; moderate doses (30–50 g) dose depen-
dently increase postprandial TG, whereas very high doses
(>80 g) result in an exaggerated postprandial TG response
[17–20]. In addition, the extent of postprandial lipemia is
influenced by other dietary components, such as the content
of protein [21•], fatty acid, glucose, or alcohol [22–24].
However, although metabolic ward testing (oral fat-loading
test) may provide useful mechanistic information, it may
not reflect regular, free-living daytime conditions. Interest-
ingly, a relatively novel approach captures a daylong TG
profile through serial capillary measurements [25, 26]. In
one study, participants were provided with a TG analyzer
(TG-specific point-of-care testing device) to determine their
own daytime TG profile at several time points on three
different weekdays [26]. Thus, the daytime TG profile may
have the potential to provide information regarding real-life
TG changes and can be easily applied in clinical practice
for routine screening of populations, reflecting in-hospital
and out-of-hospital situations. Diurnal TG profiles have
been associated with insulin sensitivity, fat mass, and diet
[26]. Furthermore, the daytime TG profiles were closely
related to postprandial lipemia as assessed by an oral fat-
loading test [27]. In a recent study, van Oostrom et al. [28•]
compared different methods of investigating postprandial
lipemia in 20 male participants with reduced insulin
sensitivity and premature CAD. In their study, the TG load
(daytime capillary TG measurement profile) test was more
strongly associated with the parameters of postprandial
lipemia than a more traditional oral fat-loading test.
Postprandial Lipoproteins and CVD Risks
in Nondiabetic Populations
The associations of postprandial TG in response to normal
food intake and cardiovascular events were the focus of
several recent, large, prospective cohort studies. The
Copenhagen City Heart Study [12••] investigated the role
of postprandial TG in a nondiabetic population made up of
7587 women and 6394 men (20–93 years of age) observed
over 26 years. After a fat tolerance test, plasma TG levels
reached a mean peak level of 2.3 mmol/L, whereas the
mean peak level at 4 h after a normal food intake was
1.6 mmol/L. After adjusting for other cardiovascular risk
factors (eg, age, total cholesterol, body mass index,
hypertension, diabetes, smoking, alcohol consumption,
physical inactivity, lipid-lowering therapy, and postmeno-
pausal status and hormone therapy in women), elevated
postprandial TG levels were associated with increased risk
of MI, ischemic heart disease, death [12••], and ischemic
stroke in men and women [9•]. Another study by the same
group of investigators confirmed these findings [8•].
Interestingly, the authors detected only minimal changes
in the levels of lipids, lipoproteins, and apolipoproteins in
response to normal food intake in the general population,
which raises the issue of what might convey the increased
postprandial CVD risk. Another large prospective study
(the Women’s Health Study) made up of 26,509 healthy US
women older than 45 years of age (20,118 fasting; 6391
nonfasting participants) with 11.4 years of follow-up
studied the association of fasting and postprandial TG
levels and risk of future cardiovascular events [11••]. The
authors found that higher postprandial TG levels were
strongly associated with an increased risk of future events,
independent of other risk factors (including HDL choles-
terol and markers of insulin resistance). The hazard ratios
62 Curr Diab Rep (2010) 10:61–69for increasing tertiles of postprandial TG levels were as
follows: 1.0 (reference), 1.44 (95% CI, 0.90–2.29), and
1.98 (95% CI, 1.21–3.25; P=0.006 for trend). Associations
were strongest among individuals who had blood drawn 2–
4 h after a normal meal. Compared with the Copenhagen
City Heart Study [12••], TG levels and event rate seemed to
be considerably lower in the healthy US women. A recent
study based on the Women’s Health Study demonstrated
that besides the TG level, postprandial HDL cholesterol,
total/HDL cholesterol ratio, and apoA-1 levels predicted
CVD [29••]. In contrast, postprandial total, LDL, and non-
HDL cholesterol, in addition to apo B-100 levels and apo
B-100/A-1 ratio, provided less useful CVD risk information
[29••]. A significant association has been found between
postprandial apo B-48 levels and the progression of CAD
[30], and high levels of intestinally derived lipoproteins are
associated with increased cardiovascular risk [31, 32].
Although the exact mechanisms remain to be established,
previous studies have demonstrated that chylomicron
remnants can enter the subendothelial space of the vascular
wall with the potential to induce or participate in the
development of atherosclerotic lesions [33, 34].
Postprandial Lipoproteins in Type 2 Diabetes Mellitus
InsulinresistanceandDMareassociatedwithmultipleplasma
lipid and lipoprotein abnormalities, including exaggerated
postprandial lipemia, as well as increased CVD risk [35, 36].
Under normal, nondiabetic conditions, the postprandial
plasma concentration of insulin is high, resulting in reduced
endogenous VLDL production and reduced lipolysis from
adipose tissue. However, in DM, the presence of insulin
resistance leads to an increased capacity for VLDL-TG
secretion and an increased residence time of TRL (Fig. 1).
Insulin inhibits the production of large, buoyant VLDL1
particles (Svedberg’s flotation unit, 60–400), and overpro-
duction of these particles has been reported in patients with
DM in the postprandial state [37, 38]. In patients with DM,
there is further increased production of apo B and reduced
lipoprotein lipase activity, both of which can potentially
promote a more pronounced postprandial response [39]. In
addition, remnant lipoproteins, which are more likely to
accumulate during conditions of partially reduced lipolysis,
may be subject to reduced clearance through heparin sulfate
proteoglycans under these conditions [40]. An increased
postprandial residence time of TRL provides opportunities
for lipid exchange of TG for cholesteryl esters between
VLDL and LDL, mediated by cholesteryl ester transfer
protein and resulting in TG enrichment of LDL particles and
elevated formation of small, dense LDL [37]. In addition,
there is an increased likelihood of changes in the HDL
subfraction pattern in diabetes, with a reduction in the larger
HDL 2b and an increase in the smaller HDL 3b and 3c
particles [36].
Postprandial Lipoproteins and CVD Risks in Diabetic
Populations
Contrary to the situation observed in the general popula-
tion, only a few studies have examined the association
between postprandial lipemia and CVD risk in diabetes,
and the results have been inconclusive. The differential
characteristics of study designs and participants in some
studies are summarized in Table 1. Syvanne et al. [5]
investigated 30 male participants with and 30 without CAD
undergoing a fat-loading test (760 kcal, 78 g fat=92.0
energy percentage [E%]); 50% of participants in each group
had diabetes. In this study, postprandial TG levels were
increased in both diabetic patient groups, with the most
marked differences in the large VLDL1 fraction compared
with control participants. TG levels in the two diabetic
groups reached their peak levels (∼4 mmol/L) 4–6 h after
the test meal. However, the authors did not find any
association between postprandial TG and CAD events. A
subsequent study from the same group of investigators, in
which 43 (31 male, 12 female) participants with diabetes
were studied, confirmed the initial overall finding [32]. No
marked differences were found in the metabolism of
intestinally or hepatically derived TRLs in patients with
mild CAD (<50% stenosis) compared with those with
severe CAD (>50% stenosis) after an oral fat load of a fat-
rich liquid formula (∼ 50 g fat/m
2 body surface). However,
the authors observed greater postprandial excursions of apo
B-48 and apo B-100 in intermediate-density lipoproteins in
the participants with more severe CAD. Of note, there was
a gender imbalance between the two groups, with more
women in the mild coronary heart disease group compared
with the severe coronary heart disease group (50% vs 15%).
Incontrast,astudybyTenoetal.[41] conducted among 61
(40 male, 21 female) patients with DM found an association
between elevated levels of postprandial TG and increased
carotid intima-media thickness (IMT) as assessed by
ultrasonography. None of the study participants had clinical
evidence of CVD or ischemic heart disease, and postprandial
lipid levels were measured 4 h after a standard test meal that
resembled a commonly consumed diet (9 kcal/kg; 20.0E%
fat). Notably, patients with normal fasting TG who devel-
oped postprandial hypertriglyceridemia had significantly
greater carotid IMT than patients who remained normotri-
glyceridemic during the postprandial state. Postprandial
plasma glucose, postprandial TG, and fasting LDL choles-
terol levels were all independently correlated with carotid
IMT; however, postprandial TG level showed the strongest
correlation with the extent of carotid IMT (P=0.002). The
Curr Diab Rep (2010) 10:61–69 63findings of this study suggest that the role of postprandial
hypertriglyceridemia in predicting CVD risks in the diabetic
population may be more important in the early stages of
atherosclerosis development.
Furthermore, a later study by Carstensen et al. [42]
demonstrated that diabetic male patients with MI (n=17)
had a higher response of plasma TG and retinyl palmitate—
used as a marker of intestinal remnant lipoproteins—
compared with diabetic male patients without MI (n=15).
Postprandial TG levels at 6 (4.6 vs 2.8 mmol/L; P=0.04) and
8 h (3.6 vs 2.4 mmol/L; P=0.03), as well as the incremental
area under the curve for the postprandial period (560 vs
297 mmol×480 min/L; P=0.048) after a fat-loading test
(1027 kcal, 86.6 g fat=77.0 E%) were increased in patients
with MI compared with those in patients without MI. The
authors suggested that the contradictory outcomes of their
study and those by Syvanne et al. [5] and Mero et al. [32]
may be due to differences in 1) study populations, 2) severity
of CAD, 3) diets and meal testing, 4) medications, and 5)
degree of matching of the control and case groups. The
participants in the study by Carstensen et al. [42]w e r e
almost a decade older, had higher body mass index, and may
have had more severe CAD (as they had verified MI). They
were also fed a high-carbohydrate diet for 3 days before the
fat-loading test to achieve minimal day-to-day variation in
insulin sensitivity. In addition, there were differences in the
treatment regimen, as 80% of diabetic patients with CAD
consumed β blockers, and several patients without CAD
received metformin in the study by Syvanne et al. [5]. In the
study by Carstensen et al. [42], the β-blocker treatment rate
was 41%, and metformin treatment was an exclusion
criterion. A total of 50% of those in the mild CAD group
Fig. 1 Postprandial lipoprotein metabolism in diabetes. Insulin
resistance plays a central role in the development of diabetic
dyslipidemia. Under normal physiologic conditions, insulin suppresses
lipolysis from adipose tissue and hepatic very low density lipoprotein
(VLDL) production. However, hyperinsulinemia in the postprandial
state and insulin resistance in type 2 diabetes initiates a dyslipidemic
triad of high triglyceride, low high-density lipoprotein (HDL)
cholesterol and high small, dense low-density lipoprotein (LDL)
levels. Prolonged residence of triglyceride-rich lipoproteins (TRLs)
in the circulation promotes the transfer of HDL or LDL cholesteryl
esters for triglyceride, mediated by cholesteryl ester transfer protein
(CETP). LDL can undergo hydrolysis by hepatic lipase (HL)o r
lipoprotein lipase (LPL), which hydrolyzes triglycerides from the core
of LDL, resulting in production of smaller, denser particles. Moreover,
triglyceride-enriched HDL particles become smaller, denser (HDL 3b
and 3c) and are more rapidly catabolized, contributing to low plasma
HDL in insulin resistance and type 2 diabetes. apo apolipoprotein; CM
chylomicron; FFA free fatty acid; RLP remnant lipoprotein
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Curr Diab Rep (2010) 10:61–69 65in the study by Mero et al. [32] received insulin, compared
with 22% of the severe CAD group, whereas insulin therapy
was an exclusion criterion in the study by Carstensen et al.
[42]. In the Mero et al. [32] study, the glycemic control in the
mildCAD groupwas significantlyworsethanthat of thesevere
CAD group (P=0.007); the duration of the diabetes was
longer in the mild CAD group (P=0.04); and the mild CAD
group had a skewed gender distribution, with 50% female
compared with nearly all male patients in the severe CAD
group (P=0.013), all of which may impact the findings.
As previous studies have yielded inconsistent findings
regarding the association between postprandial TG and
CAD severity among diabetic populations, Reyes-Soffer et
al. [43••] recently tested the hypothesis that more subtle
differences (eg, size and number of TRLs) may be a better
discriminator for case-control status under diabetic con-
ditions. They conducted a cross-sectional, case-control
study with 8.7 years of follow-up in diabetic individuals
(84 with, 80 without CAD). It was hypothesized that
diabetic patients with and without CAD would have similar
postprandial TG levels, but patients with CAD would have
a greater number of small postprandial lipoprotein particles
(in the density range of d<1.006 [a mixture of chylomi-
crons, chylomicron remnants, and VLDL]). However, no
significant association between the presence of CAD and
any measures of postprandial lipoproteins (postprandial TG,
d<1.006 TG, postprandial apo B-48, total apo B, d<1.006
particle number and size distributions, or remnant lipopro-
tein levels) after a high fat-loading test using a high-fat
liquid formula (1.237 kcal/2 m
2 body surface, 75.0 E% fat)
was noted. Gender-specific analysis revealed no case-
control difference. Notably, there were no significant
differences in postprandial lipoproteins at baseline between
individuals without CAD at baseline who did not develop
(n=33) or who subsequently developed CAD (n=36) and
the original CAD group patients. A significant difference
between the study by Carstensen et al. [42] and that by
Reyes-Soffer et al. [43••] was a difference in the fasting TG
level between cases and control participants. TG levels were
30% higher in cases than control participants (2.35 vs
1.80mmol/L) inthe formerstudy,whereas levelsweresimilar
in cases and control participants (1.63 vs 1.68 mmol/L) in the
latter study. Because fasting TG is a major determinant of
postprandial TG levels [44], the differences in the fasting TG
levels between cases and control participants in the study by
Carstensen et al. [42] may have contributed to the observed
differences in the postprandial TG excursions. Another
difference was the longer duration of diabetes and higher
hemoglobin A1c (HbA1c) levels, indicating worse glycemic
control in the latter study. However, although HbA1c levels
were considerably lower in the three previous postprandial
studies in diabetic patients [5, 32, 42], two of them [5, 32]
found essentially the same results as the study by Reyes-
Soffer et al. [43••]. This suggested that a difference in HbA1c
levels might not impact substantially on any association
between postprandial TG and case-control status.
Elevated LDL levels are associated with increased CVD
risk, and small, dense LDL particles, relatively more common
in diabetes, have a high susceptibility to oxidation. Oxidative
modification of LDL results in rapid uptake by macrophages,
which leads to foam cell formation and promotion of the
expression of intercellular adhesion molecule-1 [45]. Further-
more, LDL oxidation in the postprandial state seems to be
affectedbyanacuteincreaseinglycemia.ApoBinLDLcanbe
modifiedbyadvancedglycosylationendproducts,reducingthe
binding affinity of the LDL-modified particles to their hepatic
receptors and subsequently leading to increased oxidation of
these particles [46]. In addition, glycated and oxidized LDL
particles induce the release of foam cell cytokines (tumor
necrosis factor-α, interleukin-1), which play important roles in
the atherosclerotic process [47, 48]. Thus, oxidative modifi-
cation of LDL may contribute to higher CVD risk among
diabetic patients, and elevated levels of TG may contribute to
the rapid LDL oxidation seen in DM.
Tentolouris et al. [49] demonstrated that normotriglyceri-
demic diabetic patients with microalbuminuria had threefold
increased postprandial TG levels compared with diabetic
patients without microalbuminuria after ingestion of a
standard mixed test meal (783 kcal, 52.5 E% fat). Micro-
albuminuria is an established independent risk factor for CVD
in patients with DM, and its association with excessive
postprandial lipemia may partially explain the increased CVD
risk in this group of patients. Postprandial TG increase in DM
patients with diabetic nephropathy was markedly higher than
it was in those without diabetic nephropathy [50], and the
fasting apo B-48 level was elevated in individuals with
advanced diabetic nephropathy [51]. A later study by the
same group of investigators showed that apo B-48 after a
standard test meal (460 kcal, 18.0 g fat=35.0 E%) was
significantly higher in patients with diabetic nephropathy than
in control participants and was significantly associated with an
increase in small, dense LDL particles [52].
Conclusions
Overall, unlike the situation in the nondiabetic population, in
which measurement ofpostprandialTGlevelshas beenuseful
inidentifying individualsathigh riskfor the presence ofCVD
and future CVD events, specifically testing for postprandial
TG level has to date shown considerably less promise in
patients with DM. One possibility is that the predictive power
of measuring postprandial TG to identify CVD risk is
diminished in diabetes due to an already altered lipid and
lipoprotein metabolism. Furthermore, once diabetes develops,
patients are exposed to a wide variety of other risk factors that
66 Curr Diab Rep (2010) 10:61–69place them at increased risk for developing CVD. In the
UnitedKingdomProspectiveDiabetesStudy,fastingTGlevel
was associated with CAD after adjusting for age and sex but
was not an independent risk factor when other variables were
includedinthemodel[53]. Thus, the high level of CVD risks
in patients with DM exposed to a high cardiovascular risk
phenotype may make it more difficult to identify any
independent contribution of individual risk factors. For
example, obesity, decreased physical activity, and raised
insulin concentrations provide an increased risk for CVD in
the general population but have not been associated with risk
in patients with DM [53]. These variables are also risk
factors for diabetes, but once diabetes has developed,
increased levels of LDL cholesterol, decreased levels of
HDL cholesterol, presence of hypertension, microalbuminu-
ria, and hyperglycemia are likely greater risk factors for
CVD. To put this in simple terms, the risk contributed by
postprandial lipemia may drown in the sea of risk factors in
patients with DM. However, these findings do not suggest an
absence of any association between postprandial lipemia and
CVD risk in diabetic populations. Instead, the mixed
message in the studies to date provides a challenge to
develop more precise approaches or tools that could allow us
to assess the association of postprandial TG levels and CVD
risks in more detail. At present, further studies are needed to
establish the clinical usefulness of measuring postprandial
TG in individuals with DM as a tool to assess a high risk for
CVD.
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